Abstract:Macrocyclic peptides are predominantly peptide structures bearing one or more rings and spanning multiple amino acid residues. Macrocyclization has become a common approach for improving the pharmacological properties and bioactivity of peptides. A variety of ribosomal-derived and non-ribosomal synthesized cyclization approaches have been established. The biosynthesis of backbone macrocyclic peptides using seven new emerging methodologies will be discussed with regard to the features and strengths of each platform rather than medicinal chemistry tools. The mRNA display variant, known as the random nonstandard peptide integrated discovery (RaPID) platform, utilizes flexible in vitro translation (FIT) to access macrocyclic peptides containing nonproteinogenic amino acids (NAAs). As a new discovery approach, the ribosomally synthesized and post-translationally modified peptides (RiPPs) method involves the combination of ribosomal synthesis and the phage screening platform together with macrocyclization chemistries to generate libraries of macrocyclic peptides. Meanwhile, the split-intein circular ligation of peptides and proteins (SICLOPPS) approach relies on the in vivo production of macrocyclic peptides. In vitro and in vivo peptide library screening is discussed as an advanced strategy for cyclic peptide selection. Specifically, biosynthetic bicyclic peptides are highlighted as versatile and attractive modalities. Bicyclic peptides represent another type of promising therapeutics that allow for building blocks with a heterotrimeric conjugate to address intractable challenges and enable multimer complexes via linkers. Additionally, we discuss the cell-free chemoenzymatic synthesis of macrocyclic peptides with a non-ribosomal catalase known as the non-ribosomal synthetase (NRPS) and chemo-enzymatic approach, with recombinant thioesterase (TE) domains. Novel insights into the use of peptide library tools, activity-based two-hybrid screening, structure diversification, inclusion of NAAs, combinatorial libraries, expanding the toolbox for macrocyclic peptides, bicyclic peptides, chemoenzymatic strategies, and future perspectives are presented. This review highlights the broad spectrum of strategy classes, novel platforms, structure diversity, chemical space, and functionalities of macrocyclic peptides enabled by emerging biosynthetic platforms to achieve bioactivity and for therapeutic purposes.

Histidine-bridged cyclic peptide natural products: isolation, biosynthesis and synthetic studies

Opportunities and Challenges from Current Investigations into the Biosynthetic Logic of Nosiheptide-Represented Thiopeptide Antibiotics

Histidine as a key modulator of molecular self-assembly: Peptide-based supramolecular materials inspired by biological systems

Cyclic peptide therapeutics: past, present and future

Current Synthetic Approaches to Peptide and Peptidomimetic Cyclization

Biosynthetic Strategies for Macrocyclic Peptides

Discovery and biosynthesis of tricyclic copper-binding ribosomal peptides containing histidine-to-butyrine crosslinks

Peptide/protein-based Macrocycles: from Biological Synthesis to Biomedical Applications

Macrocyclic Peptide Construction Through C-H Activation Strategy.

Ribosomal peptides with polycyclic isoprenoid moieties

Design, synthesis, and applications of ring‐functionalized histidines in peptide‐based medicinal chemistry and drug discovery

Synthesis and Functionalization of Azetidine‐Containing Small Macrocyclic Peptides

Cyclodepsipeptides: Isolation, Bioactivities, Biosynthesis and Total Synthesis

Form and Function in Cyclic Peptide Natural Products: A Pharmacokinetic Perspective

CyclicPepedia: a knowledge base of natural and synthetic cyclic peptides

Current synthetic chemistry towards cyclic antimicrobial peptides

Biocompatible Synthesis of Macrocyclic Thiazol(in)e Peptides

Cyclic Peptides in Pipeline: What Future for These Great Molecules?

Cyclic Peptides from Graspetide Biosynthesis and Native Chemical Ligation

Cyclotides, a Novel Ultrastable Polypeptide Scaffold for Drug Discovery

Synthetic-bioinformatic natural product-inspired peptides